{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:56:08Z","timestamp":1781862968260,"version":"3.54.5"},"reference-count":22,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Genomictree, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: The stool DNA-based SDC2 methylation (meSDC2) test has emerged as a promising noninvasive tool for the early detection of colorectal cancer (CRC). This study aimed to validate the clinical performance of the meSDC2 test for CRC detection in a multicenter hospital setting. Materials and Methods: This prospective, retrospective, multicenter, single-blind, case\u2013control study was conducted at three tertiary medical centers. The primary endpoints were sensitivity and specificity for CRC detection. Secondary endpoints included test performance by tumor stage and location, and positivity rates in non-CRC lesions. Results: Among 636 participants, 260 (40.9%) had CRC, 173 (27.2%) had colorectal polyps, and 182 (28.6%) had normal colonoscopy findings. The meSDC2 test demonstrated a sensitivity of 87.7% (95% CI: 83.7\u201391.7%) and a specificity of 86.2% (95% CI: 82.7\u201389.7%) for CRC detection, with an AUC of 0.869 (95% CI: 0.841\u20130.895). Specificity among participants with negative colonoscopy findings was 91.8%. Positivity rates were 28.3% (95% CI: 15.3\u201341.3%) for advanced adenomas and 13.8% (95% CI: 6.6\u201321.0%) for non-advanced adenomas. Compared with the fecal immunochemical test (FIT), the meSDC2 test showed significantly higher sensitivity, whereas FIT demonstrated higher specificity. Combined testing improved sensitivity to 95.6% and 82.4% specificity. The meSDC2 test also showed significantly greater sensitivity than FIT for early-stage CRC (p = 0.037), while combined testing further improved sensitivity for both early- and late-stage CRC(p = 0.037 and p = 0.006, respectively). Conclusions: The stool-based meSDC2 test demonstrated high sensitivity, specificity, and consistent diagnostic performance across subgroups, supporting its clinical utility as a reliable and noninvasive CRC screening tool.<\/jats:p>","DOI":"10.3390\/diagnostics16121901","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:18:43Z","timestamp":1781860723000},"page":"1901","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Validation Study of Methylated Syndecan-2 in Stool DNA for the Detection of Colorectal Cancer"],"prefix":"10.3390","volume":"16","author":[{"given":"Hyoung Il","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2136-3578","authenticated-orcid":false,"given":"Yoon Dae","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Colorectal Surgery, Department of Surgery, Severance Hospital, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9403-230X","authenticated-orcid":false,"given":"Jae Myung","family":"Cha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0639-5632","authenticated-orcid":false,"given":"Nam Kyu","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Colorectal Surgery, Department of Surgery, Yongin Severance Hospital, Seoul 16995, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"ref_1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11894-019-0703-8","article-title":"The rise of colorectal cancer in Asia: Epidemiology, screening, and management","volume":"21","author":"Onyoh","year":"2019","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_3","first-page":"104","article-title":"Strategy for early detection of colon cancer","volume":"79","author":"Huh","year":"2010","journal-title":"Korean J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3393\/ac.2018.08.02.1","article-title":"Characteristics and survival of Korean patients with colorectal cancer based on data from the Korea Central Cancer Registry data","volume":"34","author":"Hur","year":"2018","journal-title":"Ann. Coloproctol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.5124\/jkma.2017.60.11.893","article-title":"Screening strategy for colorectal cancer according to risk","volume":"60","author":"Han","year":"2017","journal-title":"J. Korean Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.gastro.2005.05.056","article-title":"A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population","volume":"129","author":"Morikawa","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14309\/ajg.0000000000000465","article-title":"Stage-specific sensitivity of fecal immunochemical tests for detecting colorectal cancer: Systematic review and meta-analysis","volume":"115","author":"Niedermaier","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-019-0642-0","article-title":"Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA","volume":"11","author":"Han","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.14309\/ajg.0000000000003044","article-title":"A stool DNA-based SDC2 methylation test for the early detection of colorectal cancer in an asymptomatic, high-risk population: A multicenter prospective randomized trial","volume":"120","author":"Kim","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5009\/gnl18286","article-title":"Syndecan-2 methylation as a new biomarker for early detection of colorectal neoplasm","volume":"12","author":"Kim","year":"2018","journal-title":"Gut Liver"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jmoldx.2013.03.004","article-title":"Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer","volume":"15","author":"Oh","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2023.22231","article-title":"Multitarget stool RNA test for colorectal cancer screening","volume":"330","author":"Barnell","year":"2023","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4143\/crt.2022.1432","article-title":"Overview of the national cancer screening program for colorectal cancer in Korea over 14 years (2004\u20132017)","volume":"55","author":"Park","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13148-017-0426-3","article-title":"Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer","volume":"9","author":"Oh","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ma, L., Qin, G., Gai, F., Jiang, Y., Huang, Z., Yang, H., Yao, S., Du, S., and Cao, Y. (2022). A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA. BMC Gastroenterol., 22.","DOI":"10.1186\/s12876-022-02264-3"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"BSR20201930","DOI":"10.1042\/BSR20201930","article-title":"Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer","volume":"41","author":"Su","year":"2021","journal-title":"Biosci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-17-0153","article-title":"Stool DNA test of methylated Syndecan-2 for the early detection of colorectal neoplasia","volume":"26","author":"Niu","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zeng, T., Huang, Z., Yu, X., Zheng, L., Liu, T., Tian, B., Xiao, S., and Huang, J. (2023). Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1166796"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.5009\/gnl15479","article-title":"Performance of the fecal immunochemical test for colorectal cancer screening using different stool-collection devices: Preliminary results from a randomized controlled trial","volume":"10","author":"Shin","year":"2016","journal-title":"Gut Liver"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5009\/gnl17030","article-title":"Quality metrics of a fecal immunochemical test-based colorectal cancer screening program in Korea","volume":"12","author":"Kim","year":"2018","journal-title":"Gut Liver"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3892\/or.2014.3133","article-title":"DNA methylation status of a distinctively different subset of genes is associated with each histologic Lauren classification subtype in early gastric carcinogenesis","volume":"31","author":"Chong","year":"2014","journal-title":"Oncol. Rep."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1901\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:42:44Z","timestamp":1781862164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["diagnostics16121901"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16121901","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}